WOCKHARDT
Back to Income Statement
|
WOCKHARDT Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-463 Cr | ₹-559 Cr | ₹-244 Cr | ₹686 Cr | ₹-69 Cr |
What is the latest Consolidated Net Profit of WOCKHARDT ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹-463 Cr |
| Mar2024 | ₹-559 Cr |
| Mar2023 | ₹-244 Cr |
| Mar2022 | ₹686 Cr |
| Mar2021 | ₹-69 Cr |
How is Consolidated Net Profit of WOCKHARDT Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹-463 Cr | Negative | |
| Mar2024 | ₹-559 Cr | Negative | |
| Mar2023 | ₹-244 Cr | Negative | |
| Mar2022 | ₹686 Cr | Positive | |
| Mar2021 | ₹-69 Cr | - | |
Compare Consolidated Net Profit of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹23,318.8 Cr | 1.7% | 12.2% | -0.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,494.0 Cr | -1.5% | -4.8% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,514.0 Cr | -0.9% | -1.4% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,044.0 Cr | 0.3% | 1.6% | 12.1% | Stock Analytics | |
| CIPLA | ₹121,574.0 Cr | -0.8% | -1.2% | 1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,919.0 Cr | -0.8% | 1.7% | -5.6% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | 1.7% |
12.2% |
-0.2% |
| SENSEX | 0.7% |
0.5% |
9% |
You may also like the below Video Courses